Surgical cytoreduction in recurrent ovarian carcinoma in patients with complete response to paclitaxel-platinum

European Journal of Surgical Oncology

Volumn 31, Issue 1, 2005, Pages 67-73

  Gronlund, Bo ^a   Lundvall, L ^a   Christensen, I J ^b   Knudsen, J B ^a   Hogdall C ^a  

^a Rigshospitalet   (Denmark)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

Epithelial ovarian carcinoma; Relapse; Resectability; Secondary cytoreductive surgery; Survival

Indexed keywords

CARBOPLATIN; IFOSFAMIDE; MELPHALAN; PACLITAXEL; PLATINUM DERIVATIVE; TOPOTECAN;

ADULT; AGED; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOREDUCTIVE SURGERY; DRUG RESPONSE; FEMALE; HUMAN; MULTIVARIATE ANALYSIS; OVARY CARCINOMA; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECURRENT CANCER; SALVAGE THERAPY; TUMOR LOCALIZATION;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 12144265528     PISSN: 07487983     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejso.2004.08.016     Document Type: Article

References (29)

1. C.T. Griffiths Surgical resection of tumour bulk in the primary treatment of ovarian carcinoma Natl Cancer Inst Monogr 42 1975 101-104
2. W.J. Hoskins F.G. Lawton Primary cytoreductive surgery for advanced-stage disease In: D.M. Gershenson W.P. McGuire editors Ovarian cancer controversies in management 1998 Churchill-Livingstone Edinburgh 65-84
3. A.P. Makar J. Kisic C.G. Trope Controversies in surgical management of advanced ovarian cancer (stage III-IV) Eur J Gynaecol Oncol 21 2000 449-460
4. J.B. Vermorken S. Pecorelli Clinical trials in patients with epithelial ovarian cancer: Past, present and future Eur J Surg Oncol 22 1996 455-466
5. R.F. Ozols Recurrent ovarian cancer: Evidence-based treatment J Clin Oncol 20 2002 1161-1163
6. C. Scarabelli A. Gallo A. Carbone Secondary cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma Gynecol Oncol 83 2001 504-512
7. R.Y. Zang Z.Y. Zhang Z.T. Li et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer Eur J Surg Oncol 26 2000 798-804
8. J.S. Berek C. Trope I. Vergote Surgery during chemotherapy and at relapse of ovarian cancer Ann Oncol 10 Suppl 1 1999 3-7
9. M.A. Morgan S.C. Rubin Secondary cytoreduction in epithelial ovarian cancer Crit Rev Oncol Hematol 18 1995 1-8
10. S.C. Rubin I. Benjamin J.S. Berek Secondary cytoreductive surgery In: D.M. Gershenson W.P. McGuire editors Ovarian cancer: Controversies in management 1998 Churchill-Livingstone Edinburgh 101-114
11. G. Deppe P. Baumann Advances in ovarian cancer chemotherapy Curr Opin Oncol 12 2000 481-491
12. J.P. Neijt S.A. Engelholm M.K. Tuxen et al. Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer J Clin Oncol 18 2000 3084-3092
13. M.E. van der Burg M. van Lent M. Buyse et al. The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer N Engl J Med 332 1995 629-634
14. P. Therasse S.G. Arbuck E.A. Eisenhauer et al. New guidelines to evaluate the response to treatment in solid tumours. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada J Natl Cancer Inst 92 2000 205-216
15. G. Cormio G. di Vagno A. Cazzolla et al. Surgical treatment of recurrent ovarian cancer: Report of 21 cases and a review of the literature Eur J Obstet Gynecol Reprod Biol 86 1999 185-188
16. S.M. Eisenkop R.L. Friedman N.M. Spirtos The role of secondary cytoreductive surgery in the treatment of patients with recurrent epithelial ovarian carcinoma Cancer 88 2000 144-153
17. A. Gadducci P. Iacconi S. Cosio et al. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer Gynecol Oncol 79 2000 344-349
18. F. Janicke M. Holscher W. Kuhn et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer Cancer 70 1992 2129-2136
19. W. Kuhn B. Schmalfeldt L. Pache et al. Disease-adapted relapse therapy for ovarian cancer: Results of a prospective study Int J Oncol 13 1998 57-63
20. M. Morris D.M. Gershenson J.T. Wharton et al. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer Gynecol Oncol 34 1989 334-338
21. A. Munkarah C. Levenback J.K. Wolf et al. Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer Gynecol Oncol 81 2001 237-241
22. E.H. Tay P.T. Grant V. Gebski et al. Secondary cytoreductive surgery for recurrent epithelial ovarian cancer Obstet Gynecol 99 2002 1008-1013
23. L. Vaccarello S.C. Rubin V. Vlamis et al. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response Gynecol Oncol 57 1995 61-65
24. E.A. Eisenhauer M. Gore J.P. Neijt Ovarian cancer: Should we be managing patients with good and bad prognostic factors in the same manner? Ann Oncol 10 Suppl. 1 1999 9-15
25. A. Gadducci P. Conte C. Cianci et al. Treatment options in patients with recurrent ovarian cancer Anticancer Res 21 2001 3557-3564
26. J. Ricke J. Sehouli C. Hach et al. Prospective evaluation of contrast-enhanced MRI in the depiction of peritoneal spread in primary or recurrent ovarian cancer Eur Radiol 13 2003 943-949
27. R.E. Bristow F. Simpkins H.K. Pannu et al. Positron emission tomography for detecting clinically occult surgically resectable metastatic ovarian cancer Gynecol Oncol 85 2002 196-200
28. L.M. Chen B.Y. Karlan Recurrent ovarian carcinoma: Is there a place for surgery? Semin Surg Oncol 19 2000 62-68
29. S.M. Eisenkop R.H. Nalick N.N. Teng Modified posterior exenteration for ovarian cancer Obstet Gynecol 78 1991 879-885